Effect of raltegravir on estradiol and norgestimate plasma pharmacokinetics following oral contraceptive administration in healthy women

AIMS: Oral contraceptives such as norgestimate–ethinyl estradiol (Ortho Tri-Cyclen®) are commonly prescribed in the HIV-infected patient population. A placebo-controlled, randomized, two-period crossover study in healthy HIV-seronegative subjects was conducted to assess the effect of raltegravir on...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Anderson, Matt S, Hanley, William D, Moreau, Allison R, Jin, Bo, Bieberdorf, Frederick A, Kost, James T, Wenning, Larissa A, Stone, Julie A, Wagner, John A, Iwamoto, Marian
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Science Inc 2011
Teme:
Short Reports
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3080652/
https://ncbi.nlm.nih.gov/pubmed/21395656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2010.03885.x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items